Persistent antidepressant effect of low-dose ketamine and activation in the supplementary motor area and anterior cingulate cortex in treatment-resistant depression: A randomized control study

被引:42
作者
Chen, Mu-Hong [1 ,2 ]
Li, Cheng-Ta [1 ,2 ,4 ]
Lin, Wei-Chen [2 ,4 ]
Hong, Chen-Jee [1 ,2 ,4 ]
Tu, Pei-Chi [1 ,2 ,3 ]
Bai, Ya-Mei [1 ,2 ]
Cheng, Chih-Ming [2 ]
Su, Tung-Ping [1 ,2 ,3 ,4 ,5 ]
机构
[1] Natl Yang Ming Univ, Fac Med, Div Psychiat, Taipei, Taiwan
[2] Taipei Vet Gen Hosp, Dept Psychiat, 201,Sec 2,Shih-Pai Rd, Taipei 112, Taiwan
[3] Taipei Vet Gen Hosp, Dept Med Res, Taipei, Taiwan
[4] Natl Yang Ming Univ, Inst Brain Sci, Taipei, Taiwan
[5] Gen Cheng Hsin Hosp, Dept Psychiat, Taipei, Taiwan
关键词
Ketamine; Treatment-resistant depression; PET; Supplementary motor area; Dorsal anterior cingulate cortex; UNIPOLAR DEPRESSION; RESIDUAL SYMPTOMS; PREFRONTAL CORTEX; PET SCANS; DISORDER; REMISSION; BRAIN; ADOLESCENTS; OUTCOMES; CARE;
D O I
10.1016/j.jad.2017.09.008
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: A single low-dose ketamine infusion exhibited a rapid antidepressant effect within 1 h. Despite its short biological half-life (approximately 3 h), the antidepressant effect of ketamine has been demonstrated to persist for several days. However, changes in brain function responsible for the persistent antidepressant effect of a single low-dose ketamine infusion remain unclear Methods: Twenty-four patients with treatment-resistant depression (TRD) were randomized into three groups according to the treatment received: 0.5 mg/kg ketamine, 0.2 mg/kg ketamine, and normal saline infusion. Standardized uptake values (SUVs) of glucose metabolism measured through F-18-FDG positron-emission-tomography before infusion and 1 day after a 40-min ketamine or normal saline infusion were used for subsequent whole-brain voxel-wise analysis and were correlated with depressive symptoms, as defined using the Hamilton Depression Rating Scale-17 (HDRS-17) score Results: The voxel-wise analysis revealed that patients with TRD receiving the 0.5 mg/kg ketamine infusion had significantly higher SUVs (corrected for family-wise errors, P = 0.014) in the supplementary motor area (SMA) and dorsal anterior cingulate cortex (dACC) than did those receiving the 0.2 mg/kg ketamine infusion. The increase in the SUV in the dACC was negatively correlated with depressive symptoms at 1 day after ketamine infusion Discussion: The persistent antidepressant effect of a 0.5 mg/kg ketamine infusion may be mediated by increased activation in the SMA and dACC. The higher increase in dACC activation was related to the reduction in depressive symptoms after ketamine infusion. A 0.5 mg/kg ketamine infusion facilitated the glutamatergic neurotransmission in the SMA and dACC, which may be responsible for the persistent antidepressant effect of ketamine much beyond its half-life.
引用
收藏
页码:709 / 714
页数:6
相关论文
共 38 条
[1]   KETAMINE'S MECHANISM OF ACTION: A PATH TO RAPID-ACTING ANTIDEPRESSANTS [J].
Abdallah, Chadi G. ;
Adams, Thomas G. ;
Kelmendi, Benjamin ;
Esterlis, Irina ;
Sanacora, Gerard ;
Krystal, John H. .
DEPRESSION AND ANXIETY, 2016, 33 (08) :689-697
[2]   HF-rTMS Treatment in Medication-Resistant Melancholic Depression: Results from 18FDG-PET Brain Imaging [J].
Baeken, Chris ;
De Raedt, Rudi ;
Van Hove, Christian ;
Clerinx, Peter ;
De Mey, Johan ;
Bossuyt, Axel .
CNS SPECTRUMS, 2009, 14 (08) :439-448
[3]   Cognitive and emotional influences in anterior cingulate cortex [J].
Bush, G ;
Luu, P ;
Posner, MI .
TRENDS IN COGNITIVE SCIENCES, 2000, 4 (06) :215-222
[4]   Neural Correlates of Rapid Antidepressant Response to Ketamine in Treatment-Resistant Unipolar Depression: A Preliminary Positron Emission Tomography Study [J].
Carlson, Paul J. ;
Diazgranados, Nancy ;
Nugent, Allison C. ;
Ibrahim, Lobna ;
Luckenbaugh, David A. ;
Brutsche, Nancy ;
Herscovitch, Peter ;
Manji, Husseini K. ;
Zarate, Carlos A., Jr. ;
Drevets, Wayne C. .
BIOLOGICAL PSYCHIATRY, 2013, 73 (12) :1213-1221
[5]   Neurostimulation as an intervention for treatment resistant depression: From research on mechanisms towards targeted neurocognitive strategies [J].
De Raedt, Rudi ;
Vanderhasselt, Marie-Anne ;
Baeken, Chris .
CLINICAL PSYCHOLOGY REVIEW, 2015, 41 :61-69
[6]  
Dignam P, 2009, AUST NZ J PSYCHIAT, V43, P87
[7]   Comparing the actions of lanicemine and ketamine in depression: key role of the anterior cingulate [J].
Downey, Darragh ;
Dutta, Arpan ;
McKie, Shane ;
Dawson, Gerard R. ;
Dourish, Colin T. ;
Craig, Kevin ;
Smith, Mark A. ;
McCarthy, Dennis J. ;
Harmer, Catherine J. ;
Goodwin, Guy M. ;
Williams, Steve ;
Deakin, J. F. William .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 (06) :994-1003
[8]   What happens to patients with treatment-resistant depression? A systematic review of medium to long term outcome studies [J].
Fekadu, Abebaw ;
Wooderson, Sarah C. ;
Markopoulo, Kalypso ;
Donaldson, Catherine ;
Papadopoulos, Andrew ;
Cleare, Anthony J. .
JOURNAL OF AFFECTIVE DISORDERS, 2009, 116 (1-2) :4-11
[9]   THE RELATIONSHIP BETWEEN GLOBAL AND LOCAL CHANGES IN PET SCANS [J].
FRISTON, KJ ;
FRITH, CD ;
LIDDLE, PF ;
DOLAN, RJ ;
LAMMERTSMA, AA ;
FRACKOWIAK, RSJ .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1990, 10 (04) :458-466
[10]   Influence of the normalization template on the outcome of statistical parametric mapping of PET scans [J].
Gispert, JD ;
Pascau, J ;
Reig, S ;
Martínez-Lázaro, R ;
Molina, V ;
García-Barreno, P ;
Desco, M .
NEUROIMAGE, 2003, 19 (03) :601-612